In addition, no significant difference was observed in Bcl-2 transcript expression between the ER+ and ER− breast cancer groups (P = 0.840) and HER-2+ and HER-2− breast cancer groups (P = 0.336) (Table 4). This evidence concerns the gene BCL2 and breast carcinoma.